HomeCompareIDRA vs EPRT

IDRA vs EPRT: Dividend Comparison 2026

IDRA yields 470.59% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IDRA wins by $38545.05M in total portfolio value
10 years
IDRA
IDRA
● Live price
470.59%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38545.12M
Annual income
$27,182,357,871.92
Full IDRA calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — IDRA vs EPRT

📍 IDRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIDRAEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IDRA + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IDRA pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IDRA
Annual income on $10K today (after 15% tax)
$40,000.00/yr
After 10yr DRIP, annual income (after tax)
$23,105,004,191.13/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, IDRA beats the other by $23,104,993,276.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IDRA + EPRT for your $10,000?

IDRA: 50%EPRT: 50%
100% EPRT50/50100% IDRA
Portfolio after 10yr
$19272.59M
Annual income
$13,591,185,356.32/yr
Blended yield
70.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

IDRA
Analyst Ratings
5
Buy
4
Hold
Consensus: Buy
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IDRA buys
0
EPRT buys
0
No recent congressional trades found for IDRA or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIDRAEPRT
Forward yield470.59%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$38545.12M$63.4K
Annual income after 10y$27,182,357,871.92$12,840.73
Total dividends collected$37542.88M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: IDRA vs EPRT ($10,000, DRIP)

YearIDRA PortfolioIDRA Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$57,759$47,058.82$11,205$505.18+$46.6KIDRA
2$315,826$254,024.51$12,672$682.46+$303.2KIDRA
3$1,636,076$1,298,141.44$14,490$930.48+$1.62MIDRA
4$8,035,425$6,284,824.27$16,786$1,282.69+$8.02MIDRA
5$37,445,846$28,847,941.19$19,753$1,791.56+$37.43MIDRA
6$165,706,448$125,639,392.36$23,677$2,541.64+$165.68MIDRA
7$696,916,266$519,610,366.98$29,008$3,672.99+$696.89MIDRA
8$2,788,074,169$2,042,373,764.24$36,463$5,425.08+$2788.04MIDRA
9$10,619,401,952$7,636,162,591.12$47,238$8,221.57+$10619.35MIDRA
10$38,545,117,961$27,182,357,871.92$63,385$12,840.73+$38545.05MIDRA

IDRA vs EPRT: Complete Analysis 2026

IDRAStock

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Full IDRA Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this IDRA vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IDRA vs SCHDIDRA vs JEPIIDRA vs OIDRA vs KOIDRA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.